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Abstract
Background: The frequency of mild forms of hepatitis A, especially in children, could lead to underreporting. The
objective of the study was to investigate the sensitivity of two surveillance systems, mandatory Statutory Disease
Reports and the Microbiological Reporting System of Catalonia, using capture-recapture techniques.
Methods: The study was conducted in Catalonia between 2011 and 2015. Hepatitis A cases reported to two
independent surveillance systems were included: Statutory Disease Reports (SDR) and Microbiological Reporting
System of Catalonia (MRS). The variables collected were: age, sex, year of declaration, size of municipality (< 10,000
and ≥ 10,000), country of birth (Spain or abroad), reporting centre (primary care/hospital) and notification method
(electronic or paper). The capture-recapture analysis and the estimate of 95% confidence intervals were made using
the Chapman formula for comparison of two sources, both for the estimate of the total number of cases and the
stratification according to variables. Multinomial logistic regression was performed to obtain an adjusted estimate.
Results: The SDR had a greater overall sensitivity than the MRS (48.8%; 43.5–55.6 vs. 19.3%; 17.2–21.9). In cases aged
< 15 years the sensitivity of both systems was higher (76.6%; 72.7–81 vs. 25.2%; 20.9–29.5) than in cases aged > 15
years (25.5%; 22.8–28.3 vs. 12.1%; 10–14.2). For those born in Spain, the sensitivity was 57.2% (49.6–67.4) in the SDR
and 27.1% (23.5–31.9) in the MRS, lower than that for foreign-born patients (58%; 51.2–66.8 vs. 49.1%; 43.4–56.6). In
electronically-reported cases, the sensitivity was much higher in the SDR than in the MRS (47.2%; 42.3–52.1 vs. 9.4%;
6.5–12.3). No differences were observed according to sex, size of municipality, and year of declaration or reporting
centre. The estimated total number of cases using the Chapman formula was very similar to the adjusted estimate
(1121; 985–1258 vs. 1120; 876–1525), indicating the robustness of the results.
Conclusions: The sensitivity of the SDR was greater than that of MRS, especially in patients aged < 15 years,
although for patients born abroad the difference in sensitivity was lower. Reinforced surveillance combining the
SDR and MRS improves the efficiency in the detection of cases.
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Background
The Statutory Disease Reporting System (SDR) is a
passive surveillance system through which health profes-
sionals declare all infectious diseases subject to surveil-
lance in Catalonia (Spain): the reporting systems and
procedures are regulated by a Decree that must be com-
plied with [1, 2]. Suspicion is sufficient to notify the
SDR. The reporting physician may have the suspicion or
confirmation of hepatitis A and, when reporting, should
declare whether the notification is due to suspicion or
laboratory confirmation.
The Microbiological Reporting System of Catalonia
(MRS) is a surveillance system based on microbiologists
reporting microorganisms that cause acute infectious
diseases in Catalonia [3]. The MRS is based on reporting
only laboratory-confirmed cases and does not notify
cases ruled out (negative and false positive IgM).
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The SDR and MRS are complementary and their inte-
grated management constitutes a reinforced surveillance
system capable of improving the detection of cases of
diseases under surveillance.
Although all public or private health professionals are
required to report any suspicion of any disease covered
by the SDR, in practice there is underreporting by some
professionals and, in consequence, the real incidence of
the disease is underestimated. Among the main causes
of underreporting are not knowing the obligation to re-
port the disease, not appreciating the importance of
doing so, and the pressures on health care [4].
Knowledge of the real incidence of diseases is also af-
fected by underdetection. In the case of hepatitis A in
children aged < 6 years, the infection is asymptomatic
(without jaundice) in approximately 70% of children,
which leads to underdetection. However, in adolescents
and adults, 70% of cases are symptomatic [5]. The re-
sources allocated by public health services to surveil-
lance systems are limited, and periodic evaluation
contributes to maximizing their efficiency [6].
The capture-recapture method is a statistical method
for estimating the real incidence of diseases in a given
population. It consists of studying, for two or more in-
formation sources, the number of cases detected by one
source and the number of cases detected in the two or
more sources used (coincident cases) to estimate cases
not detected by the different sources used [7]. This
method has the advantage of being much cheaper than
others based on an active search for cases and allows
similar results to be obtained [8]. The conditions for ap-
plication of the capture-recapture methodology are [7,
8]: a) the population under study has to be closed, i.e.,
there should be no changes during the time in which the
capture of cases occurs in the systems compared; b)
there must be a method of determining whether an indi-
vidual identified by one source is the same as an individ-
ual identified in the other system; c) each individual
must have the same probability of being captured by ei-
ther system; d) the systems must be independent. The
aim of this study was to investigate the sensitivity of two
surveillance systems using the capture-recapture method:
the SDR and the MRS in Catalonia.
Methods
Information sources
The SDR is based on physicians reporting suspected
cases of diseases deemed to be of mandatory report.
One of the main functions of the SDR is epidemiological
surveillance and control of these diseases and outbreaks
of any aetiology considered as a priority for control in
Catalonia, a Spanish region with 7.5 million inhabitants,
which includes hepatitis A. The mere suspicion of hepa-
titis A by a physician means it must be reported as a
suspected case. The reporting physician may have a sus-
picion or a confirmed case of hepatitis A and the report
must state whether the case is suspected or laboratory
confirmed (in which case the method of confirmation
must be stated).
In Catalonia, there are definitions for suspected and
confirmed cases of hepatitis A. Cases included in the
SDR must meet one of the following definitions:
Suspected case
A case that meets the clinical case definition.
Clinical case definition
Person with discrete onset of symptoms (malaise, ab-
dominal pain, anorexia, diarrhoea, nausea, intermittent
vomiting, arthralgia) and one of the following three
symptoms: fever, jaundice or elevated serum aminotrans-
ferase levels.
Confirmed case
(1) A case that meets the clinical case definition and is
confirmed by laboratory tests: positive IgM against hepa-
titis A (anti-HAV positive), or (2) A case that meets the
clinical case definition and is epidemiologically-linked to
a confirmed case.
All cases reported to the SDR are reviewed to verify
that they meet the definition of a suspected or con-
firmed case. Cases that do not meet the definition of
suspected cases are classified as “non-cases” and are
excluded.
This study only includes cases that met the case
definition and were laboratory confirmed or were
epidemiologically-linked to a confirmed case: suspected
cases were excluded.
The MRS is a basic information system that belongs to
the epidemiological surveillance network of Catalonia.
The MRS collects information on microorganisms caus-
ing infectious diseases detected by laboratories partici-
pating in the system. The main objectives of the MRS
are to provide information on certain diseases through
the identification of the microorganisms involved and to
determine trends and changes in the epidemiological
patterns of microorganisms and microbiological resist-
ance. Until 2015, the MRS was a voluntary surveillance
system which covered 82% of acute hospital beds [2].
At the end of 2015, Catalonia drafted new legislation
to harmonize the list of diseases to be subject to moni-
toring in accordance with the European norm. Under
this new regulation, the MRS went from a voluntary
reporting system to a system of obligatory declaration.
In the years included in the study (2011–2015), the la-
boratories participating in the MRS did so voluntarily.
Professionals working in the Microbiology services of
Catalonia involved in the system reported detections of
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specific anti-HAV IgM, providing data to identify the
case (name).
Notification data in both the SDR and MRS are con-
tained in an application in which data exploitation and
analysis can be managed. The SDR and MRS are inter-
connected, since the two systems are complementary for
communicable disease surveillance, but the independ-
ence of the sources is maintained. Cases that meet the
clinical case definition and are epidemiologically linked
to a confirmed case are not declared to the MRS be-
cause, by definition, they do not require confirmation,
and are detected by the SDR.
Data collection
MRS: We extracted all records coded for hepatitis A (con-
firmed cases) reported from January 2011 to December
2015 from the MRS. Likewise, we extracted all hepatitis re-
cords from the SDR dataset for the same study period. We
then linked the databases using the personal identification
code (PIC). When the PIC was not available, the date of re-
port, age and sex were used to identify duplicates between
the two sources. In cases with inconclusive/unclear match-
ing, the hospital was used as a fifth matching criterion. The
variables recorded for each case were age, sex, year of re-
port, size of municipality (< 10,000 and ≥ 10,000), country
of birth, type of report (electronic or paper) and centre of
report (hospital or primary care centre).
SDR: Confirmed cases reported to the SDR according
to the confirmed case definition were selected. Con-
firmed case: case that meets the clinical case definition
and is laboratory-confirmed (specific anti-HAV IgM), or
a case that meets the clinical case definition and is
epidemiologically-linked to a confirmed case.
The study was not submitted for research ethics approval
as the activities described were conducted as part of the
legislated mandate of the Health Department of Catalonia,
the competent authority for the surveillance of communic-
able diseases, which is officially authorized to receive, treat
and temporarily store personal data on cases of infectious
disease according to Decree 203/2015 of the 15 September
which created the epidemiological surveillance network
[2]. Therefore, all study activities formed part of public
health surveillance and were thus exempt from institu-
tional board review and did not require informed consent.
Personal data were used only for evaluation during the
matching process. All the necessary measures to protect
the confidentiality of personal data were taken during
the whole evaluation (access to the data restricted to the
personnel involved in data analysis and removal of per-
sonal data from the datasets after matching).
Statistical methods
The total number of hepatitis A cases was estimated
using the two-source capture-recapture method that
uses Chapman’s formula [9] to reduce bias due to small
samples:
N ¼ L1þ 1ð Þ L2þ 1ð Þ
aþ 1 −1
95%CI ¼ N 1:96
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
L1þ 1ð Þ L2þ 1ð Þ L1−að Þ L2−að Þ
aþ 1ð Þ2 aþ 2ð Þ
s
where L1 is the number of cases in the SDR dataset, L2
is the number of cases reported to the MRS, and a is the
number of cases captured by both systems. The sensitiv-
ity (Se) of case ascertainment by the two sources is cal-
culated as the proportion of true cases detected by each
source, i.e. Se(1) = L1/N for source 1 and Se(2) = L2/N
for source 2. Sensitivity for the two sources when they
are combined was calculated as the proportion of cases
detected by one of the two sources or both, i.e. Se(1,2)
= (L1 + L2-a)/N.
Estimates were made for the entire 5-year period and
additionally stratified by age group, sex, year of report,
size of municipality, country of birth, centre of report
and type of report. (electronic or paper).
The independence of the sources was considered when
applying the capture-recapture method [10, 11]. In the
two-by-two table, where a represents cases reported by
two sources or combinations of sources, b and c cases
reported exclusively by either of the two sources, and x
the estimated cases not reported by either of the
sources, the odds ratio (OR = ax/bc) should not signifi-
cantly differ from one.
A multinomial logit model [12, 13] was used to evalu-
ate patient characteristics to the probability of capture,
which allows more precise estimates of the number of
estimated cases [14]. This identifies patient characteris-
tics related to the probability of capture by the different
sources. We used a backwards stepwise procedure (using
likelihood ratio tests, with a p-value of > 0.2 as the cri-
terion for removing variables from the model) [15, 16]
to eliminate covariates, starting with a full model includ-
ing all potential covariates and using the parameter esti-
mates from the model to estimate the sizes of
population subgroups and calculate the estimated inci-
dence. We also derived confidence intervals which allow
for the uncertainty in estimating the total number of
cases. All analyses were made using R software version
3.0.1.
Results
The distribution of patient characteristics by source is
shown in Table 1. The mean age was 20.6 years in the
SDR and 27.5 years in the MRS; 55% of patients were
aged < 15 years in the SDR and 46% in the MRS. The
male-female percentage was 56% vs.44% in the SDR, and
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58% vs. 42% in the MRS. The number of Spanish-born
patients was 34% in the SDR and 41% in the MRS and,
in both cases was higher than the number of
foreign-born patients. Paper was the main form of report
(66% in the SDR and 83% in the MRS). The centre of re-
port was 34% primary healthcare and 33% hospital in
the SDR and 70% hospital reports and 30% primary
healthcare in the MRS.
Capture-recapture analysis
The odds ratio (OR) to verify the independence of the
two sources was 0.99 (95% CI 0.69–1.29), reinforcing the
independence of the sources.
From 2011 to 2015, 547 cases were reported to the
SDR (503 laboratory-confirmed and 44 without labora-
tory confirmation but epidemiologically-linked to a
laboratory-confirmed case) and 216 to the MRS, 105
cases were included in both sources. The estimated total
number of case reports expected during the whole
period was 1121 (95% CI 985–1258) (Table 2). A de-
crease in the number of reported cases was observed be-
tween 2011 (134 cases) and 2015 (74 cases) and no
outbreak was detected during the study period. The sen-
sitivity was 48.8% (95%CI 43.5–55.6%) for the SDR and
19.3% (95%CI 17.2–21.9%) for the MRS (Table 3). The
estimated total number of cases was statistically signifi-
cant (p-value< 0.001) which means there were differ-
ences between the sensitivity of the two sources.
Sensitivity increased to 58.7% (95%CI 54.9–62.4%) when
the datasets were combined.
Table 3 shows the unreported cases, the estimated
number of cases and the sensitivity for both sources
stratified by the characteristics considered.
The sensitivity was 76.6% (95%CI 72.7–81.0) for the
SDR and 25.2% (95%CI 20.9–29.5) for the MRS in the <
15 years age group, and 25.5% (95%CI 22.8–28.3) for the
SDR and 12.1% (95%CI 10.0–14.2) for the MRS in the
≥15 years age group: the differences were statistically sig-
nificant (p-value< 0.001). The 2–4 years age group had
the highest sensitivity in both the SDR and MRS: 81.3%
(95%CI 70.7–95.7) in the SDR and 27.5% (95%CI 23.8–
32.3) in the MRS (Fig. 1). The sensitivity of the two
sources was very similar between males (SDR 46.4%;
95%CI 39.8–55.7% and MRS 19.0%; 95%CI 16.3–22.8)
and females (SDR 52.6%; 95%CI 44.9–63.6 and MRS
19.8 95%CI 16.9–24.0), without significant differences.
Table 1 Hepatitis A patient characteristics by source, Catalonia
2011–2015
SDR (n = 547) MRS (n = 216)
Age at report, years
Mean (SD) 20.6 (18.6) 27.5 (23.1)
Median (IQR) 10 (29) 25 (40)
< 2 years, n (%) 29 (5.3%) 8 (3.7%)
2–4 years, n (%) 77 (14.1%) 26 (12.0%)
5–14 years, n (%) 196 (35.8%) 65 (30.1%)
15–24 years, n (%) 21 (3.8%) 8 (3.7%)
25–34 years, n (%) 92 (16.8%) 22 (10.2%)
35–44 years, n (%) 68 (12.4%) 28 (13.0%)
45–54 years, n (%) 33 (6.0%) 29 (13.4%)
> 55 years, n (%) 31 (5.7%) 29 (13.4%)
NAs 0 (0.0%) 1 (0.5%)
Sex, n (%)
Male 308 (56.3%) 126 (58.3%)
Female 239 (43.7%) 90 (41.7%)
NAs 0 (0.0%) 0 (0.0%)
Year of report, n (%)
Year 2011 134 (24.5%) 18 (8.3%)
Year 2012 127 (23.2%) 50 (23.1%)
Year 2013 107 (19.6%) 31 (14.3%)
Year 2014 101 (18.5%) 62 (28.7%)
Year 2015 74 (13.5%) 55 (25.5%)
NAs 4 (0.7%) 0 (0.0%)
Size of municipality, n (%)
< 10,000 people 115 (21.0%) 75 (34.7%)
≥ 10,000 people 430 (78.6%) 127 (58.8%)
NAs 2 (0.4%) 14 (6.5%)
Country of birth, n (%)
Spain 186 (34.0%) 88 (40.7%)
Other countries 92 (16.8%) 78 (36.1%)
NAs 269 (49.2%) 50 (23.1%)
Type of report, n (%)
Electronic 184 (33.6%) 37 (17.1%)
Paper 363 (66.4%) 179 (82.9%)
NAs 0 (0.0%) 0 (0.0%)
Centre of report, n (%)
Primary healthcare centre 184 (33.6%) 65 (30.1%)
Hospital 182 (33.3%) 151 (69.9%)
NAs 181 (33.1%) 0 (0.0%)
NAs Not available
Table 2 Capture-recapture analysis of two datasets to estimate
the total number of hepatitis A cases, Catalonia 2011–2015
SDR Total
Identified Not identified
MRS Identified 105 111 216
Not identified 442 463 905
Total 547 574 1121
SDR Statutory Disease Reporting
MRS Microbiological Reporting System of Catalonia
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No differences were observed according to the size of
the municipality.
Comparing sensitivities by country of birth was statis-
tically significant (p-value< 0.001) due mainly to the sen-
sitivity of the MRS, with 27.1% (95%CI 23.5–31.9) for
Spanish-born people and 49.1% (95%CI 43.4–56.6%) for
foreign-born people. Paper reports were the most used
by the two sources and the sensitivity for the SDR was
similar, but electronic report had a sensitivity of 9.4%
(95%CI 6.5–12.3%) while on paper it was 15.3% (95%CI
13.2–17.4%; p < 0.001). There were no significant differ-
ences in sensitivity according to the type of centre for ei-
ther source: the sensitivity was 32.8% (95% CI 27.5–
40.6%) in the SDR and 27.2% (95%CI 22.8–33.7) in the
MRS for hospitals and 69.6 (95%CI61.2–80.6%) and
24.5% (21.6–28.5%) for primary healthcare.
The final multinomial logit model obtained after the
stepwise procedure shows the characteristics that ex-
plain the identification of cases by the two sources and,
therefore, the sensitivity of the two sources in identifying
hepatitis A cases in Catalonia. The results of the multi-
nomial logit model are shown in Table 4. In the final
multivariate model, the variables considered statistically
significant in defining the sensitivity of the two sources
were the age at report (< 15 vs. > = 15 years), the country
of birth and the type of report. Other variables that were
also important in explaining the sensitivity of the two
sources were the year of report (2011 to 2013 vs.2014 to
2015) and the centre of report. The odds of being identi-
fied by one of the two sources for the ≥15 years age
group was 0.44 times (95%CI 0.26–0.74) that of the < 15
years age group; the odds for people born in Spain were
0.25 times (95% CI 0.15–0.43) that for foreign-born
people; and the odds for paper reporting were 0.36 times
(95%CI 0.21–0.64) that for electronic reporting. With
these variables in the model, the adjusted estimate of the
total number of cases was 1120 (95%CI 876–1525). This
estimate was similar to that obtained by Chapman’s for-
mula, suggesting the results were consistent and robust.
Discussion
The results of this study provide robust estimates due to
the fact that the sources studied are independent and be-
cause the assumption of independence was confirmed.
Various authors have employed capture-recapture
methods using independent sources that are the same or
very similar to those we used to assess the sensitivity of
different sources of the surveillance system for hepatitis
A and other diseases. Overhage et al. [17] used two
sources to assess hepatitis A surveillance completeness:
a) automated electronic laboratory reports and b) spon-
taneous reporting by physicians: Durosoy et al. [18] also
used two sources of hepatitis A surveillance: a) labora-
tory results and b) notifications by physicians. Matin et
al. [19], in a study that assessed how many cases of
hepatitis A are not reported, used three data sources: a)
the Laboratory Reporting System, b) the Local Health
Protection Unit and c) data derived from a specific pro-
ject on hepatitis A genotyping.
The sensitivity of the SDR was greater than that of the
MRS in both the global and the subgroup analyses. This
may be because the SDR system is compulsory and has
100% coverage throughout Catalonia while, in the years
analysed, the MRS system was voluntary and encompassed
around 80% of Catalonia healthcare services. In addition,
the SDR also includes a few clinically-compatible but not
laboratory-confirmed cases which were epidemiologically-
linked to a laboratory-confirmed case.
The new Decree [2] has established the obligatory na-
ture of report to the MRS system by public and private
hospital and primary healthcare microbiology laborator-
ies in Catalonia. Future studies are required to deter-
mine whether this change affects the completeness of
reporting from this source and, if so, to quantify the
changes.
Other factors that contribute to the lower sensitivity of
the MRS with respect to hepatitis A are that the
Fig. 1 Cases by age groups reported to MRS and SDR systems and
estimation cases by capture-recapture method
Table 4 Variables defining the sensitivity of the sources in
detecting hepatitis A. Multinomial Logit model
OR (95%CI) p-value
Age at notification (≥ 15 years) 0.44 (0.26, 0.74) 0.002
Year of declaration (2014–2015) 0.65 (0.40, 1.07) 0.089
Country of birth (Spain) 0.25 (0.15, 0.43) < 0.001
Type of notification (Paper) 0.36 (0.21, 0.64) < 0.001
Centre of notification (Hospital) 1.59 (0.92, 2.76) 0.099
OR odds ratio
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serological tests necessary for the diagnosis of hepatitis
A are not performed in all reporting microbiology la-
boratories, so some hospitals do not report cases. In
addition, 70% of reports to the MRS are hospital-based
and hepatitis A is detected mainly in primary healthcare
centres.
Although the real incidence of clinical cases of hepa-
titis A is difficult to ascertain due to underreporting,
evaluating the sensitivity of the sources used for disease
surveillance is of interest because it may help to improve
the detection of cases and the adoption of appropriate
control measures [16, 20].
Our study underlines the importance of integrating in-
formation from different sources to monitor, prevent
and control outbreaks [21].
Reviews of hepatitis A only or of foodborne diseases in-
cluding hepatitis A in developed countries [22, 23] have
found that hepatitis A is frequently underreported, as did
the results of the study by Simmons et al. [24], who
assessed the completeness of the notification system by
comparing notifications with laboratory-confirmed cases
of hepatitis A and other foodborne illnesses.
A meta-analysis of the completeness of the reporting
of hepatitis A cases between 1997 and 2015 obtained
heterogeneous results, ranging from 4 to 97%. Differ-
ences were attributed to factors such as the type of
source used for case detection, reporting mechanisms
(automatic methods, other methods) and staffing infra-
structure [22].
A Turkish study by Durosoy et al. to determine the
completeness of two sources (reporting and laboratory)
for various diseases (hepatitis, brucellosis, syphilis, mea-
sles and HIV/AIDS) found that only 31.6% of cases of
hepatitis A reported by the laboratory had been notified
to the surveillance system. The incidence rates calcu-
lated from the cases reported to the surveillance system
placed the region at the level of low incidence for hepa-
titis A, whereas if the cases identified by the laboratory
were added, the incidence level increased and placed the
region in the intermediate incidence zone [18]. A 2006
capture-recapture study conducted in England found
high underreporting of hepatitis A cases, with a com-
pleteness of 27.8% (95% CI 19–38.7% [19].
In the present study, the sensitivity was significantly
greater in cases in children aged < 15 years than in those
aged ≥15 years, both for the SDR (76.6%, 72.7–81) and
the MRS (25.2%, 20.9–29.5). The 2–4 years age group
had the greatest sensitivity for both sources (81.3% for
the SDR system versus 27.5% for the MRS). The sensitiv-
ity fell with increasing age, especially in the SDR, and
from 45 years of age upwards was slightly below 20% for
both sources. Although most capture-recapture studies
do not analyse the sensitivity of the different sources
across different age groups [23], the New Zealand study
by Simmons et al. of foodborne diseases also showed a
greater sensitivity for reporting hepatitis A in younger
people [24]. It is difficult to find a simple explanation for
the fact that more cases were reported in children than
in adults, especially because hepatitis A is clinically more
florid in adults. In any case, our results suggest the ad-
visability of targeting health professionals to reinforce
the reporting of cases in adults.
The sensitivity of the MRS was lower than that of the
SDR throughout the study years, although it increased in
more recent years, and was 25.7% (95% CI 19.9–36.1) in
2015. The improvement in the MRS results in recent
years coincides with increased coverage of reporting to
the MRS, especially in primary healthcare.
According to the country of birth, the notification of
cases of hepatitis A in foreign-born people was more
sensitive (p value < 0.001) than that in people born in
Spain for the two sources. The country of origin is of
great relevance for the surveillance of communicable
diseases [25], and our results suggest that there is a
greater concern on the part of respondents to report
cases occurring in foreign-born people than those occur-
ring in the native population. It may be that health pro-
fessionals have a greater suspicion of hepatitis A in
people born in countries where the disease is endemic
than in people born in Spain which, in recent years, has
seen a significant decrease in the disease incidence.
Although there were no significant differences in the
results obtained in the two sources according to the type
of centre, the SDR had greater sensitivity in cases re-
ported by primary healthcare centres (69.6%) than in
cases reported by hospitals (32.8%). In contrast, in the
MRS, the sensitivity was slightly higher in hospitals
(27.2%) than in primary healthcare centres (24.5%). The
SDR results may be due to the fact that a percentage of
hepatitis A cases, especially in children, do not present
complications, and therefore are not hospitalized, with
primary healthcare professionals detecting and reporting
the disease.
In our study, the sensitivity of electronic reporting was
higher than that obtained by paper-based reports for the
SDR (47.2% vs. 31.1%), whereas the comparable figures
for the MRS were 9.4% vs. 15.3%, with the differences
being statistically significant. The greater implementa-
tion of electronic reporting in the SDR may explain
these results.
Notification by electronic procedures that must be val-
idated by epidemiological surveillance unit technicians is
increasing and adds opportunities for disease reporting
to the surveillance system. In a study carried out in
Andalusia, Spain, it was estimated that the verification
process of reports received electronically accounted for
approximately 10% of the activity of the personnel re-
sponsible for the surveillance of communicable diseases
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[26], but this not inconsiderable time is justified if, as
our data suggest, it serves to increase the sensitivity of
the system. Difficulties in the electronic transportability
of the data generated in hospitals may explain why the
sensitivity was lower for the cases reported electronically
to the MRS in our study, a limitation also reported by
other authors [27]. Overhage et al. [17] found that elec-
tronic data transmission from the laboratory increased
paper-based reporting by more than four-fold.
This study has strengths and limitations. The main
strength is that 91% of the cases reported to the two
sources had reported the PIC. The detection of coinci-
dent cases (cases declared to both sources) was made
through the PIC when this data was available. In cases
in which the PIC was not available, the study of coinci-
dent cases was made by comparing the name and sur-
name, age, sex, hospital or primary healthcare centre
and the date of report of the case.
One limitation is that, as noted above, MRS coverage
is not universal, unlike the SDR, which is. However,
since both sources should be used for the monitoring
and control of hepatitis A, we believe that this does not
invalidate the assessment of the results obtained.
The sensitivity of the sources studied for the surveil-
lance of hepatitis A cannot be generalized to other dis-
eases because physicians’ perceptions of the importance
of hepatitis A for public health differs from that of other
diseases and because laboratory confirmation methods
may be more complex for some diseases than for others
[28]. In the aforementioned New Zealand study, among
food-borne transmissible diseases, hepatitis A was the
disease for which the reporting of cases by physicians
showed the lowest sensitivity [23].
Conclusion
In conclusion, the sensitivity of enhanced surveillance by
combining two information sources (compulsory report-
ing by physicians and voluntary reporting by microbiol-
ogy laboratories) was 59%, improving the sensitivity of
each source separately and helping to improve the qual-
ity of epidemiological surveillance necessary for ad-
equate control of hepatitis A.
The resources allocated by public health services to sur-
veillance systems are limited, and periodic evaluation con-
tributes to maximizing their efficiency. Capture-recapture
methods may contribute knowledge of the true incidence
rates of communicable diseases.
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